Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

A hepatocyte targeted corn peptide-galactooligosaccharide nanoparticle for the alleviation of ethanol-induced damage in cells

AI Summary
  • Hepatocyte-targeted nanoparticles were formed by Maillard conjugation of corn peptides to galactooligosaccharides, producing CPs-GOS for liver cell delivery.
  • CPs-GOS were ~73.19 nm, uniformly spherical, storage-stable, free radical scavenging and biocompatible; galactosyl moiety drove efficient LO2 cell accumulation.
  • In LO2 hepatocytes CPs-GOS increased ethanol-challenged viability from 48.87% to 75.18% and attenuated oxidative stress, supporting therapeutic potential for alcoholic liver disease.
Summarise with AI (MRCPsych/FRANZCP)

Front Nutr. 2026 Oct 27;13:1987391. doi: 10.3389/fnut.2026.1987391. eCollection 2026.

ABSTRACT

Alcoholic liver disease is defined as damage of liver structure and function caused by prolonged heavy alcohol consumption, and novel preventive and treatment options are needed. Corn peptide (CP), which is produced through enzymatic hydrolysis of corn protein, is a bioactive polypeptide that has been used for hangover relief and liver support. To alleviate alcohol-induced damage to liver cells, we designed hepatocyte-targeted nanoparticles consisting of CPs attached via the Maillard reaction to galactooligosaccharides (GOS). The resulting CPs-GOS measured 73.19 nm in diameter, presented a uniform spherical morphology, and exhibited e storage stability, free radical scavenging ability, and biocompatibility. Importantly, the high stability and the efficient accumulation of CPs-GOS in LO2 cells can be attributed to the galactosyl component of the GOS. In cultured hepatocytes, treatment with CP-GOS increased ethanol-induced cell viability from 48.87 to 75.18%, and reduced oxidative stress. Our study demonstrated great potential for the CPs-GOS nanoparticle system as an intervention for alcoholic liver disease.

PMID:43010996 | PMC:PMC13747776 | DOI:10.3389/fnut.2026.1987391

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD